HK86588A - Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof - Google Patents

Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof Download PDF

Info

Publication number
HK86588A
HK86588A HK865/88A HK86588A HK86588A HK 86588 A HK86588 A HK 86588A HK 865/88 A HK865/88 A HK 865/88A HK 86588 A HK86588 A HK 86588A HK 86588 A HK86588 A HK 86588A
Authority
HK
Hong Kong
Prior art keywords
organic solvent
excipient
composition
vitamins
active vitamins
Prior art date
Application number
HK865/88A
Other languages
German (de)
English (en)
French (fr)
Inventor
Yuji Makino
Yoshiki Suzuki
Original Assignee
Teijin Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Limited filed Critical Teijin Limited
Publication of HK86588A publication Critical patent/HK86588A/en

Links

Classifications

    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10P—GENERIC PROCESSES OR APPARATUS FOR THE MANUFACTURE OR TREATMENT OF DEVICES COVERED BY CLASS H10
    • H10P72/00—Handling or holding of wafers, substrates or devices during manufacture or treatment thereof
    • H10P72/04—Apparatus for manufacture or treatment
    • H10P72/0446—Apparatus for mounting on conductive members, e.g. leadframes or conductors on insulating substrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10P—GENERIC PROCESSES OR APPARATUS FOR THE MANUFACTURE OR TREATMENT OF DEVICES COVERED BY CLASS H10
    • H10P72/00—Handling or holding of wafers, substrates or devices during manufacture or treatment thereof
    • H10P72/30—Handling or holding of wafers, substrates or devices during manufacture or treatment thereof for conveying, e.g. between different workstations
    • H10P72/32—Handling or holding of wafers, substrates or devices during manufacture or treatment thereof for conveying, e.g. between different workstations between different workstations
    • H10P72/3202—Mechanical details, e.g. rollers or belts
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10P—GENERIC PROCESSES OR APPARATUS FOR THE MANUFACTURE OR TREATMENT OF DEVICES COVERED BY CLASS H10
    • H10P72/00—Handling or holding of wafers, substrates or devices during manufacture or treatment thereof
    • H10P72/70—Handling or holding of wafers, substrates or devices during manufacture or treatment thereof for supporting or gripping
    • H10P72/78—Handling or holding of wafers, substrates or devices during manufacture or treatment thereof for supporting or gripping using vacuum or suction, e.g. Bernoulli chucks

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
HK865/88A 1983-02-22 1988-10-27 Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof HK86588A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58026898A JPS59155309A (ja) 1983-02-22 1983-02-22 活性型ビタミンｄ↓３類組成物

Publications (1)

Publication Number Publication Date
HK86588A true HK86588A (en) 1988-11-04

Family

ID=12206053

Family Applications (1)

Application Number Title Priority Date Filing Date
HK865/88A HK86588A (en) 1983-02-22 1988-10-27 Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof

Country Status (7)

Country Link
US (1) US4729895A (2)
EP (1) EP0116755B1 (2)
JP (1) JPS59155309A (2)
KR (1) KR880001095B1 (2)
DE (1) DE3372845D1 (2)
HK (1) HK86588A (2)
MY (1) MY101847A (2)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62149619A (ja) * 1985-09-05 1987-07-03 Teijin Ltd 活性型ビタミンｄ３類注射用組成物
GB8624628D0 (en) * 1986-10-14 1986-11-19 Scras Soluble/splitable tablets
JP2643222B2 (ja) * 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
WO1990003173A1 (fr) 1988-09-26 1990-04-05 Teijin Limited Preparation aqueuse stable a base de vitamine d3 active
JP2525478B2 (ja) * 1989-03-01 1996-08-21 帝人株式会社 安定性の改良された活性型ビタミンｄ▲下３▼類固型製剤
US5258375A (en) * 1989-03-13 1993-11-02 Ss Pharmaceutical Co., Ltd. Composition for the preparation of dosage-form active vitamins D3 containing polyvinylacetal diethylaminoacetate
JP2845342B2 (ja) * 1990-04-28 1999-01-13 大正製薬株式会社 ビタミンｄ▲下３▼誘導体含有固形製剤組成物
JPH04198129A (ja) * 1990-11-28 1992-07-17 Sumitomo Pharmaceut Co Ltd 活性型ビタミンｄ↓３類含有組成物
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
TW212761B (2) * 1991-04-09 1993-09-11 Takeda Pharm Industry Co Ltd
US5281584A (en) * 1992-02-28 1994-01-25 The Dow Chemical Company Effect of particle-size distribution of cellulose ethers on palatability of compositions
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
IL103224A (en) * 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
AU6944796A (en) * 1995-09-28 1997-04-17 Teijin Limited Preventive or remedy for hyperthyreosis
DE10127897B4 (de) * 2001-06-08 2006-04-20 Bionorica Ag Manteltablette mit Pflanzentrockenextrakten
KR100688618B1 (ko) * 2001-09-12 2007-03-09 주식회사 유유 비타민 ｄ 경구투여용 서방성 약제 조성물
EP1913102A1 (en) * 2005-08-08 2008-04-23 Sun Chemical Corporation Ir-luminescent nanocomposite pigment and sol-gel process for manufacturing thereof
WO2007047327A2 (en) * 2005-10-12 2007-04-26 Proventiv Therapeutics, Llc Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
SI3095447T1 (sl) * 2006-02-03 2022-02-28 Opko Renal, Llc Zdravljenje pomanjkanja vitamina D s 25-hidroksivitaminom D2 in 25-hidroksivitaminom D3
HUE037309T2 (hu) 2006-06-21 2018-08-28 Opko Ireland Global Holdings Ltd Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer
CA2587805C (en) * 2007-04-25 2014-02-18 The Procter & Gamble Company Improved vitamin d content uniformity in pharmaceutical dosage forms
PT3335712T (pt) 2007-04-25 2025-10-23 Opko Renal Llc Método de tratamento e prevenção seguro e eficaz do hiperparatiroidismo secundário na doença renal crónica
US8592401B2 (en) * 2007-04-25 2013-11-26 Proventiv Therapeutics, Llc Methods and compounds for vitamin D therapy
PL2148661T3 (pl) 2007-04-25 2013-07-31 Cytochroma Inc Doustne kompozycje o kontrolowanym uwalnianiu zawierające związek będący witaminą D i woskowy nośnik
DK2148684T3 (da) * 2007-04-25 2013-04-22 Cytochroma Inc Fremgangsmåde til behandling af vitamin D-insufficiens og -deficiens
EP2240036B1 (en) * 2008-02-06 2015-01-14 Innov'ia Pulverulent composition and a process for preparing the same
CN102046812A (zh) 2008-04-02 2011-05-04 赛特克罗公司 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒
PT2552484T (pt) 2010-03-29 2020-04-03 Opko Ireland Global Holdings Ltd Métodos e composições para redução dos níveis de parafróides
EP2468265A3 (en) * 2010-12-04 2013-01-02 DEEF Pharmaceutical Industries Co. Homogeneous preparations containing vitamin D
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
CN104800185B (zh) * 2015-04-22 2018-03-09 青岛正大海尔制药有限公司 阿法骨化醇缓释片及其制备方法
MY198547A (en) 2016-03-28 2023-09-04 Opko Ireland Global Holdings Ltd Methods of vitamin d treatment
TWI784997B (zh) * 2016-12-28 2022-12-01 日商中外製藥股份有限公司 包含ｅｄ-７１的固體分散體與油分散體的醫藥組合物
WO2020044314A1 (en) * 2018-08-31 2020-03-05 Opko Ireland Global Holdings, Ltd. Vitamin d pediatric dosage forms, methods of making and using

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2691619A (en) * 1951-09-18 1954-10-12 Pfizer & Co C Fat-soluble vitamin-containing products and process therefor
GB799068A (en) * 1955-12-29 1958-07-30 Hoffmann La Roche A stabilized vitamin-d composition and a process for the production thereof
GB1027675A (en) * 1963-01-07 1966-04-27 Henry Joseph Johnson Fortifying composition for water-base liquid food products
DE1492034A1 (de) * 1965-05-18 1969-02-20 Merck Ag E Verfahren zur Herstellung fester haltbarer Zubereitungen von empfindlichen,in Wasser schwer loeslichen Wirkstoffen,vorzugsweise Arzneimitteln
GB1142147A (en) * 1965-05-28 1969-02-05 Glaxo Lab Ltd A process for making free-flowing gel particles
US3957966A (en) * 1972-05-19 1976-05-18 Gaf Corporation Stabilized vitamin food coatings
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
US3826823A (en) * 1972-09-25 1974-07-30 Syntex Inc Stabilized prostaglandin preparations
JPS5418330B2 (2) * 1973-03-16 1979-07-06
JPS58401B2 (ja) * 1974-07-15 1983-01-06 明治製菓株式会社 ケイコウヨウイヤクヒンソセイブツノ セイホウ
JPS5225015A (en) * 1975-08-22 1977-02-24 Sumitomo Chem Co Ltd Process for preparing fine granular drugs
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
FR2389377A1 (en) * 1977-05-06 1978-12-01 Brohult Johan Antiinflammatory, antirheumatic medicament - comprises 1 alpha-hydroxy-cholecalciferol
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
JPS54135218A (en) * 1978-04-11 1979-10-20 Yamanouchi Pharmaceut Co Ltd Composition containing prostaglandin e
JPS5569562A (en) * 1978-11-21 1980-05-26 Teijin Ltd Stabilization of active vitamin d3 derivative
US4195078A (en) * 1979-03-09 1980-03-25 Eli Lilly And Company Nabilone granulation
JPS55136229A (en) * 1979-04-10 1980-10-23 Teijin Ltd Adjustment of bone metabolism in warm-blooded animal and drug for it
US4301146A (en) * 1980-07-29 1981-11-17 G. D. Searle & Co. Stabilization of 16-oxygenated prostanoic acid derivatives
CA1206882A (en) * 1982-02-12 1986-07-02 Hoffmann-La Roche Limited Use of cholecalciferol derivatives

Also Published As

Publication number Publication date
EP0116755A1 (en) 1984-08-29
US4729895A (en) 1988-03-08
KR850000238A (ko) 1985-02-26
DE3372845D1 (en) 1987-09-10
MY101847A (en) 1992-01-31
KR880001095B1 (ko) 1988-06-29
JPS59155309A (ja) 1984-09-04
EP0116755B1 (en) 1987-08-05
JPS6360007B2 (2) 1988-11-22

Similar Documents

Publication Publication Date Title
EP0116755B1 (en) Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof
JP3464691B2 (ja) 固型製薬組成物
EP0413828B1 (en) Solid preparation of active vitamin d3 having improved stability
JP7062246B2 (ja) ビタミンｄアナログ製剤およびその調製方法
US6531157B1 (en) Stable emulsions and dry powders of mixtures of fat-soluble vitamins, their preparations and use
EP1094841B1 (de) Pharmazeutische levothyroxinzubereitung
WO1992009271A1 (en) Composition for solid pharmaceutical preparations containing active vitamins d3 and process for preparation thereof
EP0387808A2 (en) Compositions for the preparation of dosage-form active vitamins D3 and process for preparing stable dosage-form active vitamins D3 by using the same
DE1492034A1 (de) Verfahren zur Herstellung fester haltbarer Zubereitungen von empfindlichen,in Wasser schwer loeslichen Wirkstoffen,vorzugsweise Arzneimitteln
EP0380021B1 (en) Stabilizing system for solid dosage forms
AU671536B2 (en) A process for the preparation of substantially alcohol free pharmaceutical compositions
US3655852A (en) Method of forming a stable vitamin e-c granulation
DE69532176T2 (de) Desogestrel enthaltende Tablette, Kapsel oder Granulat und Verfahren zu deren Herstellung
JPH0640921A (ja) 活性型ビタミンｄ３ 類組成物
JP2914690B2 (ja) 安定なビタミンｄ▲下３▼類含有製剤
JPH0536413B2 (2)
HU177586B (en) New process for preparing stable inclusion complexes of vitamine d with cyclodextrin
JPH03258722A (ja) ビタミンｄ↓３類含有製剤
US5258375A (en) Composition for the preparation of dosage-form active vitamins D3 containing polyvinylacetal diethylaminoacetate
HK1001996B (en) Tablet, capsule, or granule comprising desogestrel and process for making them

Legal Events

Date Code Title Description
PE Patent expired